0.0 z 5 hvězdiček
měkká vazba299 Kč
Bad Blood : Secrets and Lies in a Silicon Valley Startup
Kniha ( měkká vazba )
- Produkt je vyprodaný.
Při zaslání zboží balíčkem
K nákupu nad 499 Kč dárek zdarma v hodnotě 19 Kč
The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end.In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup `unicorn'… Přejít na celý popis
Mrtvý politik i fotbalová hvězda, zmatená Metropolitní policie a stopy vedoucí k sexuální pracovnici. Nový Robert Brynzda je tady!
Více informací
K tomuto produktu zákazníci kupují
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup `unicorn' promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work.
For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos' articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors.
In Bad Blood John Carreyrou tells the story of Theranos, and encourages us to consider the possible repercussions of our blind faith in a small group of brilliant individuals.
Now to be adapted into a film, with Jennifer Lawrence to star.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup `unicorn' promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work.
For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos' articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors.
In Bad Blood John Carreyrou tells the story of Theranos, and encourages us to consider the possible repercussions of our blind faith in a small group of brilliant individuals.
Now to be adapted into a film, with Jennifer Lawrence to star.
- Nakladatel
- Picador
- Rozměr
- 153 x 234 x 26
- jazyk
- angličtina
- Počet stran
- 339
- Vydání
- 1
- isbn
- 978-1-5098-6807-0
- Vazba
- měkká vazba
- datum vydání
- 29.05.2018
- ean
- 9781509868070
Hodnocení a recenze čtenářů Nápověda
4.5 z 5 2 hodnocení čtenářů
1× 5 hvězdiček 1× 4 hvězdičky 0× 3 hvězdičky 0× 2 hvězdičky 0× 1 hvezdička
Přidejte své hodnocení knihy
Vývoj ceny Nápověda
Získejte přehled o vývoji ceny za posledních 60 dní.
Maloobchodní cena
Minimální prodejní cena:
0 Kč
Nápověda
Další knihy autora
Články, které stojí za pozornost
-
-
-
-
-
-
-
-
-
-
-
-
